Brain Cancer Clinical Trials

The most recent listing of current clinical trials for brain cancer appears below.

Site: Brain and Nervous System

Protocol ID    Title

ACT-IV An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-Positive Glioblastoma

ALLIANCE-A221101    A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with Glioblastoma Multiforme

RTOG 0631    Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis

RTOG-0834/EORTC-26053    Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma: The CATNON Intergroup Trial

RTOG 0925    Natural history of postoperative cognitive function, quality of life, and seizure control in patients with supratentorial low-risk Grade II glioma

RTOG-1071/NCCTG-N0577    Phase III Intergroup Study Of Radiotherapy Versus Temozolomide Alone Versus Radiotherapy With Concomitant And Adjuvant Temozolomide For Patients With 1p/19q Codeleted Anaplastic Glioma

RTOG 1114    Phase II Randomized Study of Rituximab Methotrexate, Procarbazine, Vincristine, and Cytarabine with and without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma

RTOG 1122 Phase II Double-Blinded Placebo-Controlled Study Of Bevacizumab With Or Without AMG 386 In Patients With Recurrent Glioblastoma Or Gliosarcoma

RTOG-1270/N107C A Phase III Trial of Post Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease